A major limitation in aging research is the lack of reliable biomarkers to assess phenotypic changes with age or monitor response to antiaging interventions. This study investigates the role of intracellular ferrous iron (Fe2+) as a potential biomarker of senescence. Iron is known to accumulate in various tissues with age and recent studies have demonstrated that its level increases dramatically in senescent cells. The current techniques used to measure the accumulation of iron are cumbersome and only measure total iron not specific isotopes such as the redox reactive Fe2+. It is still to be determined whether the damaging form of iron (Fe2+) is specifically elevated in senescent cells. In this study, we assessed the potential use of a newly discovered Fe2+ reactive probe (SiRhoNox-1) for selective labeling of senescent cells in vitro. For this we have generated various senescent cell models and subjected them to SiRhoNox-1 labeling. Our results indicate that SiRhoNox-1 selectivity labels live senescent cells and was more specific and faster than current staining such as SA-βGal or a derived fluorescent probe C12FDG. Together these findings suggest that SiRhoNox-1 may serve as a convenient tool to detect senescent cells based on their ferrous iron level.
Get full access to this article
View all access options for this article.
References
1.
KennedyBK, BergerSL, BrunetA, et al.Aging: A common driver of chronic diseases and a target for novel interventions. Cell, 2014; 159:709–713.
2.
HöhnA, WeberD, JungT, et al.Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence. Redox Biol, 2017; 11:482–501.
3.
OgrodnikM, SalmonowiczH, GladyshevVN. Integrating cellular senescence with the concept of damage accumulation in aging: Relevance for clearance of senescent cells. Aging Cell, 2019; 18:e12841.
4.
CoppéJ-P, DesprezP-Y, KrtolicaA, CampisiJ. The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu Rev Pathol, 2010; 5:99–118.
BurdCE, SorrentinoJA, ClarkKS, et al.Monitoring tumorigenesis and senescence in vivo with a p16(INK4a)-luciferase model. Cell, 2013; 152:340–351.
7.
ChildsBG, DurikM, BakerDJ, van DeursenJM. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat Med, 2015; 21:1424–1435.
8.
BakerDJ, WijshakeT, TchkoniaT, et al.Clearance of p16 Ink4a -positive senescent cells delays ageing-associated disorders. Nature, 2011; 479:232–236.
9.
ChangJ, WangY, ShaoL, et al.Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med, 2016; 22:78–83.
10.
ZhuY, TchkoniaT, PirtskhalavaT, et al.The Achilles' heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell, 2015; 14:644–658.
11.
XuM, PirtskhalavaT, FarrJN, et al.Senolytics improve physical function and increase lifespan in old age. Nat Med, 2018; 24:1246–1256.
12.
GuerreroA, HerranzN, SunB, et al.Cardiac glycosides are broad-spectrum senolytics. Nat Metab, 2019; 1:1074–1088.
13.
Triana-MartínezF, Picallos-RabinaP, Da Silva-ÁlvarezS, et al.Identification and characterization of cardiac glycosides as senolytic compounds. Nat Commun, 2019; 10:4731.
14.
HicksonLJ, Langhi PrataLGP, BobartSA, et al.Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine, 2019; 47:446–456.
15.
DimriGP, LeeX, BasileG, et al.A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A, 1995; 92:9363–9367.
16.
Debacq-ChainiauxF, ErusalimskyJD, CampisiJ, ToussaintO. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc, 2009; 4:1798–1806.
17.
HudginsAD, TazearslanC, TareA, et al.Age- and tissue-specific expression of senescence biomarkers in mice. Front Genet, 2018; 9:59.
18.
BertoloA, BaurM, GuerreroJ, PötzelT, StoyanovJ. Autofluorescence is a reliable in vitro marker of cellular senescence in human mesenchymal stromal cells. Sci Rep, 2019; 9:2074.
19.
CheignonC, TomasM, Bonnefont-RousselotD, et al.Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol, 2018; 14:450–464.
20.
Del GiudiceR, PesceA, CozzolinoF, et al.Effects of iron on the aggregation propensity of the N-terminal fibrillogenic polypeptide of human apolipoprotein A-I. Biometals, 2018; 31:551–559.
21.
MatsuzakiM, HasegawaT, TakedaA, et al.Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. Brain Res, 2004; 1004:83–90.
22.
Bharathi, IndiSS, RaoKSJ. Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study. Neurosci Lett, 2007; 424:78–82.
23.
GruneT, JungT, MerkerK, DaviesKJA. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int J Biochem Cell Biol, 2004; 36:2519–2530.
24.
KellerJN, DimayugaE, ChenQ, et al.Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. Int. J. Biochem. Cell Biol, 2004; 36:2376–2391.
25.
LiuB, MoloneyA, MeehanS, et al.Iron promotes the toxicity of amyloid β peptide by impeding its ordered aggregation. J Biol Chem, 2011; 286:4248–4256.
26.
Ostrerova-GoltsN, PetrucelliL, HardyJ, et al.The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci, 2000; 20:6048–6054.
27.
RottkampCA, RainaAK, ZhuX, et al.Redox-active iron mediates amyloid-β toxicity. Free Radic Biol Med, 2001; 30:447–450.
28.
CookJD, FinchCA, SmithNJ. Evaluation of the iron status of a population. Blood, 1976; 48:449–455.
29.
XuJ, KnutsonMD, CarterCS, LeeuwenburghC. Iron accumulation with age, oxidative stress and functional decline. PLoS One, 2008; 3:e2865.
30.
KlangIM, SchillingB, SorensenDJ, et al.Iron promotes protein insolubility and aging in C. elegans. Aging, 2014; 6:975–988.
31.
MassieHR, AielloVR, WilliamsTR. Iron accumulation during development and ageing of Drosophila. Mech. Ageing Dev, 1985; 29:215–220.
32.
CookCI, YuBP. Iron accumulation in aging: Modulation by dietary restriction. Mech. Ageing Dev, 1998; 102:1–13.
33.
LiuJ-L, FanY-G, YangZ-S, WangZ-Y, GuoC. Iron and Alzheimer's disease: From pathogenesis to therapeutic implications. Front Neurosci, 2018; 12:632.
34.
PhilippeMA, RuddellRG, RammGA. Role of iron in hepatic fibrosis: One piece in the puzzle. World J Gastroenterol, 2007; 13:4746–4754.
35.
ZakynthinosE, VassilakopoulosT, KaltsasP, et al.Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassaemia major. Thorax, 2001; 56:737–739.
36.
FlemingDJ, JacquesPF, TuckerKL, et al.Iron status of the free-living, elderly Framingham Heart Study cohort: An iron-replete population with a high prevalence of elevated iron stores. Am J Clin Nutr, 2001; 73:638–646.
37.
KillileaDW, AtamnaH, LiaoC, AmesBN. Iron accumulation during cellular senescence in human fibroblasts in vitro. Antioxid Redox Signal, 2003; 5:507–516.
38.
MasaldanS, ClatworthySAS, GamellC, et al.Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol, 2017; 14:100–115.
39.
HirayamaT, TsuboiH, NiwaM, et al.A universal fluorogenic switch for Fe(ii) ion based on N-oxide chemistry permits the visualization of intracellular redox equilibrium shift towards labile iron in hypoxic tumor cells. Chem Sci, 2017; 8:4858–4866.
40.
ZainuddinA, ChuaKH, RahimNA, MakpolS. Effect of experimental treatment on GAPDH mRNA expression as a housekeeping gene in human diploid fibroblasts. BMC Mol Biol, 2010; 11:59.
41.
MasaldanS, ClatworthySAS, GamellC, et al.Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis. Redox Biol, 2018; 14:100–115.
42.
XiongS, SheH, TakeuchiH, et al.Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem, 2003; 278:17646–17654.
43.
SheH, XiongS, LinM, et al.Iron activates NF-kappaB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol, 2002; 283:G719–G726.
44.
KrishnamurthyJ, TorriceC, RamseyMR, et al.Ink4a/Arf expression is a biomarker of aging. J Clin Invest, 2004; 114:1299–1307.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
